Trial Profile
Sodium Stibogluconate Treatment of Leishmaniasis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Jul 2019
Price :
$35
*
At a glance
- Drugs Sodium stibogluconate (Primary)
- Indications Cutaneous leishmaniasis; Visceral leishmaniasis
- Focus Adverse reactions; Therapeutic Use
- 29 Mar 2014 New trial record